Database Integrations   Report issue

For profit Phase 3
Founded: Alpharetta GA United States (2006)

Organization Overview

First Clinical Trial
2018
NCT03377803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Database Integrations

Active Ingredients

Drugs in Phase 3 Trials (1)

vp-102 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Molluscum Contagiosum (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1